Authors

• Joseph M. Blondeau (ORCID: https://orcid.org/0000-0003-3396-0334)
• Laura F. Mataseje (ORCID: https://orcid.org/0000-0002-8014-1107)
• George R. Golding (ORCID: https://orcid.org/0000-0002-4285-4747)
• Christian Lavallée (ORCID: https://orcid.org/0000-0002-4249-8666)
• Heather J. Adam (ORCID: https://orcid.org/0000-0002-5646-6454)
• Melanie R. Baxter
• Philippe Lagacé‐Wiens (ORCID: https://orcid.org/0000-0002-5826-2869)
• Andrew Denisuik
• Denice C. Bay (ORCID: https://orcid.org/0000-0002-3620-828X)
• James A. Karlowsky (ORCID: https://orcid.org/0000-0002-1939-464X)
• Frank Schweizer (ORCID: https://orcid.org/0000-0001-8697-5519)
• Andrew Walkty (ORCID: https://orcid.org/0000-0003-2880-2104)
• Susan M. Poutanen (ORCID: https://orcid.org/0000-0003-4747-2550)
• George G. Zhanel (ORCID: https://orcid.org/0000-0002-3238-0082)
• Ross Davidson (ORCID: https://orcid.org/0000-0001-5361-0038)
• Jeremy Li (ORCID: https://orcid.org/0000-0002-1664-7613)
• Jeff Fuller

Institutions

• Western University (CA)
• Public Health Agency of Canada (CA)
• Queen Elizabeth II Health Sciences Centre (CA)
• Royal University Hospital (CA)
• Hôpital Maisonneuve-Rosemont (CA)
• Sinai Health System (CA)
• University of Manitoba (CA)

Publication Details

Journal

Journal of Antimicrobial Chemotherapy

Published

2025-08-28

DOI

https://doi.org/10.1093/jac/dkaf217

Citations

2

Primary Topic

Antibiotic Resistance in Bacteria

Type

article

Field-Weighted Citation Impact

1.18

Funders

• Pfizer
• University of Manitoba
• Merck Canada
• Sandoz Canada